GlassScriptPhysician profile
Daniel J Snyder
NPI 1073842126
$973.98
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $428 · 2022: $421 · 2023: $36.20 · 2024: $89.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $142.01 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $125.49 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.64 | 2021-2022 | |
| Amgen INC. | $118.59 | 2021-2022 | |
| Horizon Therapeutics Plc | $75.89 | 2022 | |
| Abbvie INC. | $69.88 | 2021-2024 | |
| Biohaven Pharmaceuticals, INC. | $39.48 | 2021 | |
| Csl Behring | $36.53 | 2022 | |
| Painteq LLC | $30.85 | 2024 | Painteq |
| Collegium Pharmaceutical, INC. | $28.71 | 2021 | |
| Arbor Pharmaceuticals, INC. | $22.86 | 2021-2022 | |
| Hikma Pharmaceuticals USA | $21.65 | 2022 | |
| Fidia Pharma USA INC. | $20.82 | 2024 | Hymovis, Triluron, Hyalgan |
| Redhill Biopharma INC. | $17.17 | 2022 | |
| Pfizer INC. | $16.31 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $16.29 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $16.01 | 2022 | |
| Almatica Pharma LLC | $14.26 | 2021 | |
| Zimmer Biomet Holdings, INC. | $14.09 | 2024 | Pectus Bar Bending Forceps, Standard |
| Depuy Synthes Sales INC. | $13.26 | 2021 | |
| Ethicon US, LLC | $12.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.